SBSN is shown to promote‐catenin signaling in human esophagus cancer via unknown mechanisms and its expression is a marker of colon cancer tumor endothelial cells, implicating that SBSN aberrant expression in both tumor cells and tumor‐affected healthy cells is associated with cancer malignancy. The gene discussed is SBSN; the disease is neoplasm.